欢迎来到天天文库
浏览记录
ID:53015457
大小:190.34 KB
页数:2页
时间:2020-04-12
《《阿托伐他汀对急性脑梗死患者血清超敏C反应蛋白水平及颈动脉内膜中层厚度的影响》.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、中国初级卫生保健2015年7月第29卷第7期(总第355期)阿托伐他汀对急性脑梗死患者血清超敏c反应蛋白水平及颈动脉内膜中层厚度的影响马志恒①摘要目的探讨阿托伐他汀对急性脑梗死(AcI)患者血清超敏c反应蛋白(hs—CRP)水平及颈动脉内膜中层厚度(IMT)的影响。方法78例ACI患者随机分为观察组37例和对照组41例,对照组给予吸氧、抗血小板聚集、改善微循环等常规治疗,观察组在此基础上,加用阿托伐他汀钙胶囊每晚口服,20mg,次。结果观察组总有效率89.19%(33/37),对照组总有效率68.
2、29%(28/41),差异有统计学意义(尸<0.05)。两组治疗后,采用美国国立卫生研究院卒中量表(NIHss)评分、hs—CRP水平及IMT均较治疗前下降,差异有统计学意义(尸<0.01);组间比较,观察组各指标均低于对照组,差异有统计学意义(P<0.O1)。结论在常规治疗基础上,加用阿托伐他汀可有效提高ACI的临床疗效,改善神经功能恢复,减轻炎症状态,降低IMT。关键词急性脑梗死;阿托伐他汀;超敏c反应蛋白;颈动脉内膜中层厚度doi:lO.39690.issn.1001-568X.2015.0
3、7.0059[中图分类号]R743.33[文献标识码]B[文章编号]1001—568X(2015)07—0128—02InfluenceofAtorvastatinonSerumHS—-CRPLevelandIMTinpatientswithACI/MAZhi-heng//ChinesePrimaryHealthCare,2015,29(7):128—129ABSTRACT:DBJEC玎陋Toexploretheinfluenceofatorvastatinonsel'umhigh—sensiti
4、veC—reactiveprotein(hs-CRP)levelandintimamediathicknessfIMinpatientswithacutecerebralinfarctionfACI).METHODSAtotalof78patientswithAC1wereran—domlydividedintoobservationgroup(37cases)andcontrolgroup(41cases).Routinetherapies,likeoxygeninhalation,anti—p
5、late—letaggregationandmicro-circulationimprovement,etc.,weregiventocontrolgroup,onwhichbasisatorvastatincapsulewasorallygiventoobservationgroup,20mg/d,onceeverynight.RESULTSThetotalresponseratesofobservationgroupandcontrolgroupwere89.19%(33/37)and68.2
6、9%(28/41)respectively,andtherewassignificantdifference:(P<0.05).Aftertreatment,NationalInsti—tutesofHealthStrokeScalefNIHSS1scores,hs—CRPlevelandIMTdecreasedevidentlythantreatmentbeforeinbothgroups(尸<0.01),whichwerealsosignificantlylowerinobservationg
7、roupthancontrolgroup(P<0.01).CONCLUSIONTheapplicationofatorv—astatinonthebasisofroutinetherapycanincreasetheclinicaleficacy,improvetheneurologicalrecovery,reducetheinflammatoryconditionanddecreaseIMTinACIpatients.Keywordsatorvastatin;acutecerebralinfa
8、rction;high—sensitiveC—reactiveprotein;intimamediathicknessAuthor’SaddressTheSecondPeople’SHospitalofTianshui,Tianshui,Gansu,741020,China急性脑梗死(ACI)的基础发病机制是动脉粥样硬化研究对象,入组标准:(1)符合《中国急性缺血性脑卒中诊(AS),具有高发病率、高致死率和高致残率的“三高”特治指南20l0》中的诊断标准;(2)首次发病,且发病时间
此文档下载收益归作者所有